ITabMed Co., Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| An Exploratory Study of A-337 in the Management of Malignant Solid Dose Escalation and Expansion Phases (NCT06093698) | ITabMed Co., Ltd. | 2023-12-01 |
Track ITabMed Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.